Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
NCT: NCT06248216 · RECRUITING
Brief Summary
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Frequently Asked Questions
What is Virtual Reality Therapy for Cancer-Treatment Associated Symptoms?
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms is a clinical trial registered under NCT06248216. Current status: RECRUITING.
What is the status of NCT06248216?
The current status of NCT06248216 (Virtual Reality Therapy for Cancer-Treatment Associated Symptoms) is: RECRUITING.
When did Virtual Reality Therapy for Cancer-Treatment Associated Symptoms start?
Virtual Reality Therapy for Cancer-Treatment Associated Symptoms started on 2024-12-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.